"I see Budget 2026 as an important step in India’s shift from sick-care to predictive healthcare. With initiatives like the 1,000 clinical trial sites and the ₹10,000-crore Biopharma SHAKTI mission, the government is strengthening the data and research backbone needed to move Indian health-tech from broad wellness claims to evidence-based outcomes.

Overall, I believe this is a balanced, long-term budget that aligns closely with Mr. Yoda's belief that preventive, high-precision diagnostics should become a natural part of everyday healthcare in Indian homes.”- Mr. Sudhakar Kancharla - Founder, Mr. Yoda.